Hypogonadism Completed Phase 4 Trials for Triptorelin (DB06825)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02102646MRI Substudy; Metabolic Changes Due to Iatrogenic HypogonadismTreatment